ALFA Finder| Value | ₹10.00 Cr |
|---|
BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.
Novartis India Ltd: key numbers
- Share price
- ₹1,861.50
- Market cap
- ₹4,596 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- -1151.9×Sector 43.4×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novartis India Ltd
All →Evonile Pharma Fund Raise of ₹900 Cr
Evonile Pharma's board approved a partly paid rights issue of up to Rs 900 Crore. A committee will set the issue price, record date and entitlement.
- Value
- ₹900.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Evonile Pharma Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹56.1 cr (-38% YoY) and PAT loss ₹77.5 cr, including ₹68 cr exceptional items. H1 revenue ₹159.9 cr (-10%). Transitioning to an independent branded pharma model; Minipress XL acquired.
Evonile Pharma Results Update
Evonile Pharma reported Q2 FY27 revenue of ₹56.1 crore and an EBITDA loss of ₹31.8 crore. H1 FY27 profit after tax was a loss of ₹45.3 crore.
Evonile Pharma Investor Presentation: Key Takeaways
Q2 FY27 revenue fell 38% YoY to ₹56.1 cr, with a ₹77.5 cr net loss including ₹68 cr exceptional items. Transition from single-customer model to independent distribution continues.
Evonile Pharma Q2 FY27 Results: Net Loss of ₹77.5 Cr
Evonile Pharma posted a ₹775.4 million quarterly loss for September 2026 versus profit a quarter earlier. Exceptional items of ₹682.6 million drove the half-year pre-tax loss.
- Key figure
- Net loss ₹77.5 Cr
Other partnership announcements
All →delaPlex Partnership
Delaplex Limited announced a strategic partnership with UKG to deliver workforce management consulting and implementation across India and Asia-Pacific. No monetary value or financial impact was disclosed.
Annu Projects Partnership
Annu Projects signed an MoU with GEIE Solar Products to supply materials for a JVVNL rooftop solar project. No Annu-specific consideration is stated.
Odyssey Corporation Partnership
Odyssey Corporation signed an MOU with Sinton Agribid Trading for agricultural commodity trading. The partner returns the invested capital plus a minimum profit and bears any shortfall.
Adarsh Plant Protect Partnership
Adarsh Plant Protect signed an MoU with Rapid Group and Smart Solar to form a contractual joint venture. The venture targets Nepal cook stove supply tenders.
Everest Kanto Cylinder Partnership
Everest Kanto's subsidiary EKC Egypt signed an MoU with CARGAS to study CNG transport unit manufacturing. No monetary value or orders have been committed yet.
- Execution
- One-year framework MoU, renewable for additional periods
Blue Cloud Softech Solutions Partnership
Blue Cloud Softech signed an MoU with Ghana-based Kasten Development to explore business development in Ghana and Africa. No monetary value was disclosed.